Preview: Avadel Pharmaceuticals's Earnings
Portfolio Pulse from Benzinga Insights
Avadel Pharmaceuticals (NASDAQ:AVDL) is set to release its latest quarterly earnings report on November 8, 2023. Analysts estimate an earnings per share (EPS) of $-0.37. The company's past performance shows a trend of share price increase following earnings reports, even when EPS missed estimates. The stock is currently trading at $10.74 and has seen an 84.77% increase over the last 52-week period.
November 07, 2023 | 5:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Avadel Pharmaceuticals is expected to report an EPS of $-0.37. Despite past EPS misses, the company's share price has generally increased. The stock is currently trading at $10.74, up 84.77% over the last 52 weeks.
The company's stock price has shown a trend of increasing following earnings reports, even when the EPS missed estimates. This suggests that investors may be focusing more on the company's guidance and future growth prospects rather than the EPS alone. Given the positive trend in the stock price over the past year, it is likely that the upcoming earnings report could have a positive impact on the stock price, unless there is a significant negative surprise.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100